Zonisamide Combined with Cognitive Behavioral Therapy in Binge Eating Disorder: A One-year Follow-up Study
- PMID: 20049147
- PMCID: PMC2801482
Zonisamide Combined with Cognitive Behavioral Therapy in Binge Eating Disorder: A One-year Follow-up Study
Abstract
Objective. Binge eating disorder is a serious, prevalent eating disorder that is associated with overweight. Zonisamide is an antiepileptic drug that can promote weight loss. We evaluated the efficacy and safety of zonisamide as augmentation to individual cognitive behavioral therapy in the treatment of binge eating disorder patients.
Design: controlled open study.
Participants: Twenty four threshold and subthreshold binge eating disorder patients were enrolled in the cognitive behavioral therapy treatment group, and 28 patients in the cognitive behavioral therapy plus zonisamide group.
Measurements: At the beginning (T0), at the end (T1) of treatment, and one year after the end of treatment (T2), body mass index was measured and Eating Disorder Examination-Questionnaire, Binge Eating Scale, Beck Depression Inventory, and State-Trait Anxiety Inventory were administered.Results. At T1 the cognitive behavioral therapy plus zonisamide group showed a higher mean reduction of body mass index, Eating Disorder Examination-Questionnaire, Beck Depression Inventory, and Binge Eating Scale scores. At T2, the cognitive behavior therapy group regained weight, while the cognitive behavioral therapy plus zonisamide group reduced their body mass and showed a higher reduction in binge eating frequency and Binge Eating Scale, Eating Disorder Examination-Questionnaire Restraint, and State and Trait Anxiety Inventory scores.Conclusion. The zonisamide augmentation to individual cognitive behavior therapy can improve the treatment of binge eating disorder patients, reducing body weight and the number of binge eating episodes. These results are maintained one year after the end of treatment.
Keywords: Zonisamide; binge eating disorder; cognitive behavioral therapy; overweight.
Figures
Similar articles
-
Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial.J Clin Psychiatry. 2004 Jan;65(1):50-6. doi: 10.4088/jcp.v65n0108. J Clin Psychiatry. 2004. PMID: 14744168 Clinical Trial.
-
Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial.J Clin Psychiatry. 2006 Dec;67(12):1897-906. doi: 10.4088/jcp.v67n1209. J Clin Psychiatry. 2006. PMID: 17194267 Clinical Trial.
-
Randomized Controlled Trial of an Internet-Based Cognitive-Behavioral Treatment Program for Binge-Eating Disorder.Behav Ther. 2016 Jul;47(4):500-14. doi: 10.1016/j.beth.2016.01.006. Epub 2016 Jan 22. Behav Ther. 2016. PMID: 27423166 Clinical Trial.
-
Internet-Based Cognitive Behavioral Therapy via Videoconference for Patients With Bulimia Nervosa and Binge-Eating Disorder: Pilot Prospective Single-Arm Feasibility Trial.JMIR Form Res. 2019 Oct 23;3(4):e15738. doi: 10.2196/15738. JMIR Form Res. 2019. PMID: 31647472 Free PMC article.
-
Comparing cognitive behavioural therapy for eating disorders integrated with behavioural weight loss therapy to cognitive behavioural therapy-enhanced alone in overweight or obese people with bulimia nervosa or binge eating disorder: study protocol for a randomised controlled trial.Trials. 2015 Dec 18;16:578. doi: 10.1186/s13063-015-1079-1. Trials. 2015. PMID: 26683478 Free PMC article. Clinical Trial.
Cited by
-
Pharmacological strategies for appetite modulation in eating disorders: a narrative review.Consort Psychiatr. 2023 Jul 10;4(2):79-90. doi: 10.17816/CP6150. Consort Psychiatr. 2023. PMID: 38250648 Free PMC article. Review.
-
The pharmacological options in the treatment of eating disorders.ISRN Pharmacol. 2013 Jul 15;2013:352865. doi: 10.1155/2013/352865. eCollection 2013. ISRN Pharmacol. 2013. PMID: 23956871 Free PMC article.
-
Biological therapies for eating disorders.Int J Eat Disord. 2013 Jul;46(5):470-7. doi: 10.1002/eat.22104. Int J Eat Disord. 2013. PMID: 23658094 Free PMC article. Review.
-
Binge-Eating Disorder Interventions: Review, Current Status, and Implications.Curr Obes Rep. 2023 Sep;12(3):406-416. doi: 10.1007/s13679-023-00517-0. Epub 2023 Jul 13. Curr Obes Rep. 2023. PMID: 37439970 Free PMC article. Review.
-
Therapeutic options for binge eating disorder.Eat Weight Disord. 2013 Mar;18(1):3-9. doi: 10.1007/s40519-013-0003-5. Epub 2013 Apr 9. Eat Weight Disord. 2013. PMID: 23757245 Review.
References
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder. 4. Washington, DC: American Psychiatric Press, Inc.; 1994.
-
- Pope HG, Jr, Lalonde JK, Pindyck LJ, et al. Binge eating disorder: a stable syndrome. Am J Psychiatry. 2006;163:2181–2183. - PubMed
-
- National Task Force on the Prevention and Treatment of Obesity. Dieting and the development of eating disorders in overweight and obese adults. Arch Intern Med. 2000;160:2581–2589. - PubMed
-
- Ricca V, Mannucci E, Moretti S, et al. Screening for binge eating disorder in obese outpatients. Comp Psychiatry. 2000;41:111–115. - PubMed
-
- de Zwaan M. Binge eating disorder and obesity. Int J Obes. 2001;25(1):S51–S55. - PubMed
LinkOut - more resources
Full Text Sources